Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis

Table 5 Serum inflammatory factor levels in patients with acute pancreatitis

LN (inflammatory factors pg/mL)	MAP, mean ± SE	MSAP, mean ± SE	SAP, mean ± SE	F	P value
LN (IFN-γ)	1.98 ± 0.07	2.57 ± 0.08b	3.08 ± 0.07b	53.393	0.000
LN (TNF-α)	1.63 ± 0.04	2.07 ± 0.05b	2.33 ± 0.05b,d	45.369	0.000
LN (IL-2)	1.06 ± 0.05	1.05 ± 0.06	0.99 ± 0.05	0.362	0.697
LN (IL-4)	1.02 ± 0.03	0.99 ± 0.04	0.64 ± 0.03b,d	23.195	0.000
LN (IL-5)	0.10 ± 0.05	0.10 ± 0.07	0.13 ± 0.08	0.043	0.958
LN (IL-13)	0.76 ± 0.03	0.68 ± 0.06	0.63 ± 0.07	1.703	0.187

Due to the logarithmic transformation of the data, some data are displayed as negative values. The data are expressed as mean ± SE.

^bP < 0.001 vs mild acute pancreatitis group.

^dP < 0.001 vs moderately severe acute pancreatitis group. AP: Acute pancreatitis; MAP: Mild AP; MSAP: Moderately severe AP; SAP: Severe AP; IFN-γ: Interferon-γ; TNF-α: Tumor necrosis factor-α; IL: Interleukin.